TipRanks
Go Ultimate55% OFF

AiDa Pharmaceuticals (AIDA) Financial Statements

AiDa Pharmaceuticals Financial Overview

AiDa Pharmaceuticals's market cap is currently $8.13K. The company's EPS TTM is ―; its P/E ratio is 0.00; AiDa Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 07Dec 06Dec 05
Income Statement
Total Revenue―――
Gross Profit$ 14.69M$ 15.56M$ 16.19M
Operating Income$ 5.45M$ 3.94M$ 2.12M
EBITDA$ 7.32M$ 6.02M$ 3.81M
Net Income$ 2.74M$ 1.45M$ 1.47M
Balance Sheet
Cash & Short-Term Investments―――
Total Assets$ 62.73M$ 53.81M$ 42.66M
Total Debt$ 33.37M$ 29.55M$ 25.17M
Net Debt$ 14.42M$ 22.12M$ 22.04M
Total Liabilities$ 41.54M$ 38.38M$ 32.37M
Stockholders' Equity―――
Cash Flow
Free Cash Flow$ 4.78M$ -307.77K$ 5.42M
Operating Cash Flow―――
Investing Cash Flow―――
Financing Cash Flow―――

Currency in USD